Carregant...
COVID-19 and the liver-related deaths to come
Coronavirus disease 2019 (COVID-19) itself and/or the use of hepatotoxic drugs might negatively affect the course and management of patients with pre-existing chronic liver diseases. However, the greatest effect of COVID-19 on liver diseases will be indirect and delayed, resulting from the impending...
Guardat en:
| Publicat a: | Nat Rev Gastroenterol Hepatol |
|---|---|
| Autor principal: | |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Nature Publishing Group UK
2020
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7288259/ https://ncbi.nlm.nih.gov/pubmed/32528138 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41575-020-0328-2 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|